We have audited the financial statements of Huma Therapeutics Limited (the 'parent company') and its subsidiaries (the
'group') for the year ended 31 December 2021 which comprise the Consolidated Income Statement, Consolidated Other
Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in
Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash
Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial
reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting
Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and
Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
|